DIRITHROMYCIN 500 MG ENTERIC COATED TABLET
Sponsors
Pharmaceutical Research Unit, Jordan
Conditions
Healthy
Phase 1
Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fed Condition
CompletedNCT02185846
Start: 2014-06-30End: 2014-06-30Updated: 2014-07-10
Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition
CompletedNCT02185833
Start: 2014-06-30End: 2014-06-30Updated: 2014-07-10
Semi-replicate Crossover Bioequivalence Study of Dirithromycin of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions
CompletedNCT02237768
Start: 2014-12-31End: 2014-12-31Updated: 2020-09-18
Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions
CompletedNCT02237807
Start: 2014-09-30End: 2014-10-31Updated: 2020-09-18